We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ResMed (RMD) Looks Good: Stock Adds 5.7% in Session
Read MoreHide Full Article
ResMed Inc. (RMD - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 9.8% in the past one-month time frame.
The move came after the company reported better-than-expected first-quarter fiscal 2019 results.
The company has seen a mixed track record when it comes to estimate revisions of three increases and one decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarterremained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
ResMed currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Is RMD going up? Or down? Predict to see what others think: Up or Down
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
ResMed (RMD) Looks Good: Stock Adds 5.7% in Session
ResMed Inc. (RMD - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 9.8% in the past one-month time frame.
The move came after the company reported better-than-expected first-quarter fiscal 2019 results.
The company has seen a mixed track record when it comes to estimate revisions of three increases and one decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarterremained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
ResMed currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
ResMed Inc. Price
ResMed Inc. Price | ResMed Inc. Quote
A better-ranked stock in the Medical - Products industry is Haemonetics Corporation (HAE - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is RMD going up? Or down? Predict to see what others think: Up or Down
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>